Opportunity Information: Apply for RFA DA 12 011
Apply for RFA DA 12 011
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "FY12 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jul 29, 2011 and posted on Jul 29, 2011.
- Applicants must submit their applications by Mar 27, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: County governments Special district governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Private institutions of higher education Public housing authorities/Indian housing authorities State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign (non U.S.) components of U.S. Organizations are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The FY12 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1), Funding Opportunity Number RFA-DA-12-011, is a discretionary grant program offered through the National Institutes of Health, specifically aligned with the National Institute on Drug Abuse (NIDA). It is designed to support individual scientists who demonstrate exceptional creativity and who are prepared to pursue bold, high-impact ideas in HIV/AIDS research that relate to drug abuse. The core purpose is to catalyze research that can open entirely new directions in the field or create fresh pathways toward prevention and treatment of HIV/AIDS among people who use drugs, a population that faces heightened risk and often complex barriers to care.
A defining feature of this opportunity is its emphasis on "avant garde" science, meaning proposals are expected to be highly innovative and potentially transformative rather than incremental. The program is looking for work that substantially departs from what the investigator (or the broader field) is already doing. In other words, this is meant for researchers ready to take creative, well-justified risks that could reshape understanding, prevention, or treatment approaches at the intersection of HIV/AIDS and substance use. Projects must also fit within areas identified in the Trans-NIH Plan for HIV-Related Research, which serves as a government-wide strategic framework for HIV research priorities across NIH.
From a funding and timing standpoint, the opportunity was posted on July 29, 2011, with an application closing date of March 27, 2012, and an archive date of April 27, 2012. The estimated total funding available was $2,000,000, and the award ceiling was $500,000. There was no cost sharing or matching requirement, which generally means applicants are not required to contribute non-federal funds as a condition of receiving the award. The program falls under the CFDA number 93.279 (Drug Abuse and Addiction Research Programs) and is categorized under education and health in the funding activity area.
Eligibility is broad and includes a wide range of organizations and institutions. Eligible applicants include federal, state, county, city or township governments; special district governments; public and private institutions of higher education; independent school districts; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (with the noted distinction that certain categories exclude institutions of higher education in the nonprofit listing); and for-profit organizations other than small businesses, as well as small businesses themselves. The eligibility list also extends to specific institution types and communities, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities (TCCUs). Faith-based and community-based organizations are also included. Importantly, the announcement allows participation by non-U.S. entities (foreign organizations), regional organizations, U.S. territories or possessions, and foreign (non-U.S.) components of U.S. organizations, which signals an openness to global collaboration and research settings where HIV and drug use epidemics may be especially pressing.
The administering agency is NIH, and the full details, requirements, and application instructions were provided through the NIH grants posting linked in the announcement. For technical issues accessing the announcement or linking problems, applicants were directed to contact the NIH Office of Extramural Research (OER) webmaster via the provided email address. Overall, this grant opportunity is best understood as a high-prestige, innovation-driven mechanism aimed at empowering standout investigators to pursue unconventional, field-shifting HIV/AIDS research with direct relevance to drug abuse and addiction contexts.
Frequently Asked Questions (FAQs)
What is the FY12 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1)?
The FY12 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) is a discretionary grant program offered through the National Institutes of Health (NIH) and aligned with the National Institute on Drug Abuse (NIDA). It is designed to support individual scientists who show exceptional creativity and are ready to pursue bold, high-impact ideas in HIV/AIDS research that relate to drug abuse.
What is the funding opportunity number for this grant?
The funding opportunity number is RFA-DA-12-011.
What is the main purpose of this award?
The core purpose is to catalyze research that opens entirely new directions in the field or creates new pathways toward prevention and treatment of HIV/AIDS among people who use drugs. The opportunity specifically targets the intersection of HIV/AIDS and substance use, recognizing that people who use drugs face heightened HIV risk and often complex barriers to care.
What does "avant garde" mean in the context of this program?
"Avant garde" refers to highly innovative, potentially transformative science. Proposals are expected to go beyond incremental advances and instead aim for work that could reshape understanding, prevention, or treatment approaches related to HIV/AIDS and drug abuse.
How innovative does a project need to be to fit this award?
The program emphasizes research that substantially departs from what the investigator (or the broader field) is already doing. It is intended for researchers prepared to take creative, well-justified risks that could lead to field-shifting outcomes at the HIV/AIDS and substance use intersection.
What research areas must projects align with?
Projects must fit within areas identified in the Trans-NIH Plan for HIV-Related Research, which serves as a strategic framework for HIV research priorities across NIH.
Who is the administering agency for this opportunity?
The administering agency is the National Institutes of Health (NIH), specifically aligned with the National Institute on Drug Abuse (NIDA).
When was this funding opportunity posted?
The opportunity was posted on July 29, 2011.
What was the application closing date?
The application closing date was March 27, 2012.
What was the archive date for the opportunity?
The archive date was April 27, 2012.
How much total funding was estimated to be available?
The estimated total funding available was $2,000,000.
What is the award ceiling?
The award ceiling was $500,000.
Is cost sharing or matching required?
No. The opportunity stated there was no cost sharing or matching requirement, meaning applicants were generally not required to contribute non-federal funds as a condition of receiving the award.
What is the CFDA number for this program?
The program falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs).
What funding activity area does this opportunity fall under?
The opportunity is categorized under education and health in the funding activity area.
What types of organizations are eligible to apply?
Eligibility is broad. Eligible applicants include federal, state, county, city or township governments; special district governments; public and private institutions of higher education; independent school districts; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (with a noted distinction that certain nonprofit categories exclude institutions of higher education in that listing); for-profit organizations other than small businesses; and small businesses.
Are specific institution types such as HBCUs and Hispanic-serving institutions eligible?
Yes. The eligibility list explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities (TCCUs).
Are faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations are included in the eligibility list.
Can non-U.S. (foreign) organizations apply?
Yes. The announcement allows participation by non-U.S. entities (foreign organizations), regional organizations, U.S. territories or possessions, and foreign (non-U.S.) components of U.S. organizations.
Does this opportunity support global collaboration or international research settings?
Based on the stated eligibility, the program is open to foreign organizations, regional organizations, and foreign components of U.S. organizations, signaling openness to global collaboration and research settings where HIV and drug use epidemics may be especially pressing.
Is this award intended for teams or for individual scientists?
The program is designed to support individual scientists who demonstrate exceptional creativity and readiness to pursue bold, high-impact ideas.
What population focus is highlighted in the program description?
The opportunity emphasizes HIV/AIDS prevention and treatment among people who use drugs, describing this group as having heightened risk and complex barriers to care.
Where were the full details and application instructions provided?
Full details, requirements, and application instructions were provided through the NIH grants posting linked in the announcement.
Who should applicants contact for technical issues accessing the announcement?
For technical issues accessing the announcement or problems with links, applicants were directed to contact the NIH Office of Extramural Research (OER) webmaster via the email address provided in the announcement.
How is this opportunity best characterized overall?
It is described as a high-prestige, innovation-driven mechanism aimed at empowering standout investigators to pursue unconventional, field-shifting HIV/AIDS research with direct relevance to drug abuse and addiction contexts.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Psychosocial/Behavioral Interventions and Services Research in Autism Spectrum Disorders (R34)
Previous opportunity: Pre Application for the FY12 NIDA Avant Garde Award Program for HIV/AIDS Research (X02)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 12 011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 12 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers of Biomedical Research Excellence (COBRE) (P20) Apply for PAR 11 286 Funding Number: PAR 11 286 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Pilot studies in Pancreatic Cancer (R21) Apply for PA 11 297 Funding Number: PA 11 297 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Pilot studies in Pancreatic Cancer (R03) Apply for PA 11 298 Funding Number: PA 11 298 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Drug Abuse Prevention Intervention Research (R03) Apply for PA 11 313 Funding Number: PA 11 313 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Drug Abuse Prevention Intervention Research (R01) Apply for PA 11 311 Funding Number: PA 11 311 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Prevention Intervention Research (R21) Apply for PA 11 312 Funding Number: PA 11 312 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Human Health and Heredity in Africa (H3Africa) Research Grants (U01) Apply for RFA RM 11 009 Funding Number: RFA RM 11 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Scalable Assays for Unbiased In Vitro Analysis of Neurobiological Function (R21/R33) Apply for PAR 11 319 Funding Number: PAR 11 319 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions (R21) Apply for RFA CA 11 012 Funding Number: RFA CA 11 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions (R01) Apply for RFA CA 11 011 Funding Number: RFA CA 11 011 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| mHealth Tools to Promote Effective PatientProvider Communication, Adherence to Treatment and Self Management of Chronic Diseases In Underserved Populations (R03) Apply for PA 11 331 Funding Number: PA 11 331 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| mHealth Tools to Promote Effective PatientProvider Communication, Adherence to Treatment and Self Management of Chronic Diseases In Underserved Populations (R01) Apply for PA 11 330 Funding Number: PA 11 330 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| mHealth Tools to Promote Effective PatientProvider Communication, Adherence to Treatment and Self Management of Chronic Diseases In Underserved Populations (R21) Apply for PA 11 332 Funding Number: PA 11 332 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Scholars Training for the Advancement of Research (STAR) Competitive Revision to NINR T32 Training Grants (T32) Apply for RFA NR 11 011 Funding Number: RFA NR 11 011 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of novel and emerging technologies for the accurate detection and diagnosis of polymicrobial infections in biomedical laboratory animal models (SBIR R43/R44) Apply for PA 11 340 Funding Number: PA 11 340 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Novel and Emerging Technologies for the Accurate Detection and Diagnosis of Polymicrobial Infections in Biomedical Laboratory Animal Models (STTR R41/R42) Apply for PA 11 341 Funding Number: PA 11 341 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Research Network a Research Resource within Health Care Delivery System (Limited Competition U24) Apply for RFA CA 11 502 Funding Number: RFA CA 11 502 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Cancer Institute Program Project (P01) Applications Apply for PAR 12 005 Funding Number: PAR 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44) Apply for RFA CA 12 001 Funding Number: RFA CA 12 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi Site Cancer Trials (R01) Apply for PA 12 013 Funding Number: PA 12 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 12 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.